Eli Lilly is set to dominate the GLP-1 market, according to JPMorgan. Analyst Chris Schott said Lilly's edge comes from its "best-in-class" status, and with help from its direct-to-consumer business, ...

Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month's worth of doses in a single pen. The pen could serve as a more convenient option for some ...

Novo Nordisk announced its CagriSema GLP-1 weight loss drug underperformed Eli Lilly's tirzepatide in a trial. Separately, Lilly announced patients can use a single injector to hold a month's supply ...

Eli Manning is not losing any sleep over his latest Pro Football Hall of Fame snub. Manning was not elected in his second year of eligibility, and the two-time Super Bowl champion quarterback with the ...

Eli Lilly LLY0.80%increase; green up pointing triangle received approval from the Food and Drug Administration for a label expansion of its weight-loss drug Zepbound, adding a new monthly delivery ...

It’s a good day to be the pharmaceutical giant Eli Lilly. Right now, Eli Lilly appears to be the leader in the GLP-1 race amid multiple difficult headwinds for Novo Nordisk. As of this writing, Novo ...

Eli Manning's career speaks for itself, whether enshrined or not. It's that last part that sparks debate and outrage, even if the former New York Giants' star quarterback appears unbothered. Fans, ...

Add Yahoo as a preferred source to see more of our stories on Google. Eli Lilly announced on "Good Morning America" Monday that its GLP-1 weight-loss drug Zepbound will now be available in a new multi ...

White appears to be the top internal candidate to replace Jurickson Profar (suspension) as a platoon partner for Mike Yastrzemski in left field, Gabriel Burns of the Atlanta Journal-Constitution ...

FanGraphs released their top 100 prospects for the 2026 season, and Washington Nationals 2025 first overall pick Eli Willits came in at No. 15. What got him drafted in that coveted spot was his ...

Eli Lilly, the drugmaker behind weight-loss treatments Mounjaro and Zepbound, has rapidly overtaken former market leader Novo Nordisk in the obesity drug race. While Novo’s shares have struggled this ...

The legendary quarterback, who is a two-time Super Bowl MVP, was snubbed from the pro football honor once more Kevin Sabitus/Getty Eli Manning is sharing his true feelings about missing out on the ...